346 related articles for article (PubMed ID: 23941875)
1. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism.
Stamatikos AD; Paton CM
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E767-75. PubMed ID: 23941875
[TBL] [Abstract][Full Text] [Related]
2. Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells.
Iwai T; Kume S; Chin-Kanasaki M; Kuwagata S; Araki H; Takeda N; Sugaya T; Uzu T; Maegawa H; Araki SI
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834856
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.
Pinnamaneni SK; Southgate RJ; Febbraio MA; Watt MJ
Diabetologia; 2006 Dec; 49(12):3027-37. PubMed ID: 17033839
[TBL] [Abstract][Full Text] [Related]
6. Endurance training-induced accumulation of muscle triglycerides is coupled to upregulation of stearoyl-CoA desaturase 1.
Dobrzyn P; Pyrkowska A; Jazurek M; Szymanski K; Langfort J; Dobrzyn A
J Appl Physiol (1985); 2010 Dec; 109(6):1653-61. PubMed ID: 20847127
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.
Mai K; Andres J; Bobbert T; Assmann A; Biedasek K; Diederich S; Graham I; Larson TR; Pfeiffer AF; Spranger J
Metabolism; 2012 Jan; 61(1):108-16. PubMed ID: 21741058
[TBL] [Abstract][Full Text] [Related]
8. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
9. Relationship between stearoyl-CoA desaturase 1 gene expression, relative protein abundance, and its fatty acid products in bovine tissues.
Rezamand P; Watts JS; Yavah KM; Mosley EE; Ma L; Corl BA; McGuire MA
J Dairy Res; 2014 Aug; 81(3):333-9. PubMed ID: 24904960
[TBL] [Abstract][Full Text] [Related]
10. Scd1 mammary-specific vector constructed and overexpressed in goat fibroblast cells resulting in an increase of palmitoleic acid and oleic acid.
Wang L; You J; Zhong B; Ren C; Zhang Y; Li M; Zhang G; Jia R; Ying S; Wang F
Biochem Biophys Res Commun; 2014 Jan; 443(2):389-94. PubMed ID: 24309099
[TBL] [Abstract][Full Text] [Related]
11. SCD1 activity in muscle increases triglyceride PUFA content, exercise capacity, and PPARδ expression in mice.
Rogowski MP; Flowers MT; Stamatikos AD; Ntambi JM; Paton CM
J Lipid Res; 2013 Oct; 54(10):2636-46. PubMed ID: 23918045
[TBL] [Abstract][Full Text] [Related]
12. [Stearoyl-CoA desaturase in the control of metabolic homeostasis].
Dobrzyń P
Postepy Biochem; 2012; 58(2):166-74. PubMed ID: 23214140
[TBL] [Abstract][Full Text] [Related]
13. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
[TBL] [Abstract][Full Text] [Related]
14. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
15. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
16. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
18. Stearoyl-CoA desaturase 5 (SCD5), a Δ-9 fatty acyl desaturase in search of a function.
Igal RA; Sinner DI
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158840. PubMed ID: 33049404
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming of the heart through stearoyl-CoA desaturase.
Dobrzyn P; Bednarski T; Dobrzyn A
Prog Lipid Res; 2015 Jan; 57():1-12. PubMed ID: 25482956
[TBL] [Abstract][Full Text] [Related]
20. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]